APO Research
Talk to an analyst

APO RESEARCH · REPORT

Radioactive Iodine Ablation Therapy

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Radioactive Iodine Ablation Therapy Market Outlook and Growth Opportunities 2026

8 January 2026199 pages

Choose your research edition.

Industry ResearchRadioactive Iodine Ablation Therapy Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Radioactive Iodine Ablation Therapy Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Radioactive Iodine Ablation Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Radioactive Iodine Ablation Therapy Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Radioactive Iodine Ablation Therapy Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Radioactive Iodine Ablation Therapy market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Radioactive Iodine Ablation Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Radioactive Iodine Ablation Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Radioactive Iodine Ablation Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Radioactive Iodine Ablation Therapy market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Radioactive Iodine Ablation Therapy market include Medtronic, HealthTronics, Galil Medical, AngioDynamics, Misonix, SonaCare Medical, Boston Scientific Corporation and Neuwave Medical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Radioactive Iodine Ablation Therapy market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Radioactive Iodine Ablation Therapy and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Radioactive Iodine Ablation Therapy sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Radioactive Iodine Ablation Therapy market size, projected growth trends, production technologies, key applications, and end-use industries.

Radioactive Iodine Ablation Therapy Segment by Company

Medtronic

HealthTronics

Galil Medical

AngioDynamics

Misonix

SonaCare Medical

Boston Scientific Corporation

Neuwave Medical

Radioactive Iodine Ablation Therapy Segment by Type

Gamma Radiation

Beta Radiation

Radioactive Iodine Ablation Therapy Segment by Application

Papillary Thyroid Cancer

Follicular Thyroid Cancer

Hurthle Cell Carcinoma

Other

Radioactive Iodine Ablation Therapy Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Radioactive Iodine Ablation Therapy status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Radioactive Iodine Ablation Therapy market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Radioactive Iodine Ablation Therapy significant trends, drivers, influence factors in global and regions.

6. To analyze Radioactive Iodine Ablation Therapy competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Radioactive Iodine Ablation Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Radioactive Iodine Ablation Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Radioactive Iodine Ablation Therapy.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Radioactive Iodine Ablation Therapy market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Radioactive Iodine Ablation Therapy industry.

Chapter 3: Detailed analysis of Radioactive Iodine Ablation Therapy manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Radioactive Iodine Ablation Therapy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Radioactive Iodine Ablation Therapy in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Radioactive Iodine Ablation Therapy Industry Trends Table 2. Radioactive Iodine Ablation Therapy Industry Drivers Table 3. Radioactive Iodine Ablation Therapy Industry Opportunities and Challenges Table 4. Radioactive Iodine Ablation Therapy Industry Restraints Table 5. Global Radioactive Iodine Ablation Therapy Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Radioactive Iodine Ablation Therapy Revenue Share by Company (2021-2026) Table 7. Global Radioactive Iodine Ablation Therapy Sales Volume by Company (units) & (2021-2026) Table 8. Global Radioactive Iodine Ablation Therapy Sales Volume Share by Company (2021-2026) Table 9. Global Radioactive Iodine Ablation Therapy Average Price (M USD$/units) of Company (2021-2026) Table 10. Global Radioactive Iodine Ablation Therapy Company Ranking, (2024-2026) & (USD Million) Table 11. Global Radioactive Iodine Ablation Therapy Key Company Manufacturing Base & Headquarters Table 12. Global Radioactive Iodine Ablation Therapy Company, Product Type & Application Table 13. Global Radioactive Iodine Ablation Therapy Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Radioactive Iodine Ablation Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Gamma Radiation Table 18. Significant Companies of Beta Radiation Table 19. Global Radioactive Iodine Ablation Therapy Sales Volume by Type 2021 VS 2025 VS 2032 (units) Table 20. Global Radioactive Iodine Ablation Therapy Sales Volume by Type (2021-2026) & (units) Table 21. Global Radioactive Iodine Ablation Therapy Sales Volume by Type (2027-2032) & (units) Table 22. Global Radioactive Iodine Ablation Therapy Sales Volume Share by Type (2021-2026) Table 23. Global Radioactive Iodine Ablation Therapy Sales Volume Share by Type (2027-2032) Table 24. Global Radioactive Iodine Ablation Therapy Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Radioactive Iodine Ablation Therapy Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Radioactive Iodine Ablation Therapy Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Radioactive Iodine Ablation Therapy Sales Value Share by Type (2021-2026) Table 28. Global Radioactive Iodine Ablation Therapy Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Papillary Thyroid Cancer Table 30. Significant Companies of Follicular Thyroid Cancer Table 31. Significant Companies of Hurthle Cell Carcinoma Table 32. Significant Companies of Other Table 33. Global Radioactive Iodine Ablation Therapy Sales Volume by Application 2021 VS 2025 VS 2032 (units) Table 34. Global Radioactive Iodine Ablation Therapy Sales Volume by Application (2021-2026) & (units) Table 35. Global Radioactive Iodine Ablation Therapy Sales Volume by Application (2027-2032) & (units) Table 36. Global Radioactive Iodine Ablation Therapy Sales Volume Share by Application (2021-2026) Table 37. Global Radioactive Iodine Ablation Therapy Sales Volume Share by Application (2027-2032) Table 38. Global Radioactive Iodine Ablation Therapy Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Radioactive Iodine Ablation Therapy Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Radioactive Iodine Ablation Therapy Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Radioactive Iodine Ablation Therapy Sales Value Share by Application (2021-2026) Table 42. Global Radioactive Iodine Ablation Therapy Sales Value Share by Application (2027-2032) Table 43. Global Radioactive Iodine Ablation Therapy Sales by Region: 2021 VS 2025 VS 2032 (units) Table 44. Global Radioactive Iodine Ablation Therapy Sales by Region (2021-2026) & (units) Table 45. Global Radioactive Iodine Ablation Therapy Sales Market Share by Region (2021-2026) Table 46. Global Radioactive Iodine Ablation Therapy Sales by Region (2027-2032) & (units) Table 47. Global Radioactive Iodine Ablation Therapy Sales Market Share by Region (2027-2032) Table 48. Global Radioactive Iodine Ablation Therapy Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Radioactive Iodine Ablation Therapy Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Radioactive Iodine Ablation Therapy Sales Value Share by Region (2021-2026) Table 51. Global Radioactive Iodine Ablation Therapy Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Radioactive Iodine Ablation Therapy Sales Value Share by Region (2027-2032) Table 53. Global Radioactive Iodine Ablation Therapy Market Average Price (M USD$/units) by Region (2021-2026) Table 54. Global Radioactive Iodine Ablation Therapy Market Average Price (M USD$/units) by Region (2027-2032) Table 55. Global Radioactive Iodine Ablation Therapy Sales by Country: 2021 VS 2025 VS 2032 (units) Table 56. Global Radioactive Iodine Ablation Therapy Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Radioactive Iodine Ablation Therapy Sales by Country (2021-2026) & (units) Table 58. Global Radioactive Iodine Ablation Therapy Sales Market Share by Country (2021-2026) Table 59. Global Radioactive Iodine Ablation Therapy Sales by Country (2027-2032) & (units) Table 60. Global Radioactive Iodine Ablation Therapy Sales Market Share by Country (2027-2032) Table 61. Global Radioactive Iodine Ablation Therapy Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Radioactive Iodine Ablation Therapy Sales Value Market Share by Country (2021-2026) Table 63. Global Radioactive Iodine Ablation Therapy Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Radioactive Iodine Ablation Therapy Sales Value Market Share by Country (2027-2032) Table 65. Medtronic Company Information Table 66. Medtronic Business Overview Table 67. Medtronic Radioactive Iodine Ablation Therapy Sales (units), Value (US$ Million), Price (M USD$/units) and Gross Margin (2021-2026) Table 68. Medtronic Radioactive Iodine Ablation Therapy Product Portfolio Table 69. Medtronic Recent Development Table 70. HealthTronics Company Information Table 71. HealthTronics Business Overview Table 72. HealthTronics Radioactive Iodine Ablation Therapy Sales (units), Value (US$ Million), Price (M USD$/units) and Gross Margin (2021-2026) Table 73. HealthTronics Radioactive Iodine Ablation Therapy Product Portfolio Table 74. HealthTronics Recent Development Table 75. Galil Medical Company Information Table 76. Galil Medical Business Overview Table 77. Galil Medical Radioactive Iodine Ablation Therapy Sales (units), Value (US$ Million), Price (M USD$/units) and Gross Margin (2021-2026) Table 78. Galil Medical Radioactive Iodine Ablation Therapy Product Portfolio Table 79. Galil Medical Recent Development Table 80. AngioDynamics Company Information Table 81. AngioDynamics Business Overview Table 82. AngioDynamics Radioactive Iodine Ablation Therapy Sales (units), Value (US$ Million), Price (M USD$/units) and Gross Margin (2021-2026) Table 83. AngioDynamics Radioactive Iodine Ablation Therapy Product Portfolio Table 84. AngioDynamics Recent Development Table 85. Misonix Company Information Table 86. Misonix Business Overview Table 87. Misonix Radioactive Iodine Ablation Therapy Sales (units), Value (US$ Million), Price (M USD$/units) and Gross Margin (2021-2026) Table 88. Misonix Radioactive Iodine Ablation Therapy Product Portfolio Table 89. Misonix Recent Development Table 90. SonaCare Medical Company Information Table 91. SonaCare Medical Business Overview Table 92. SonaCare Medical Radioactive Iodine Ablation Therapy Sales (units), Value (US$ Million), Price (M USD$/units) and Gross Margin (2021-2026) Table 93. SonaCare Medical Radioactive Iodine Ablation Therapy Product Portfolio Table 94. SonaCare Medical Recent Development Table 95. Boston Scientific Corporation Company Information Table 96. Boston Scientific Corporation Business Overview Table 97. Boston Scientific Corporation Radioactive Iodine Ablation Therapy Sales (units), Value (US$ Million), Price (M USD$/units) and Gross Margin (2021-2026) Table 98. Boston Scientific Corporation Radioactive Iodine Ablation Therapy Product Portfolio Table 99. Boston Scientific Corporation Recent Development Table 100. Neuwave Medical Company Information Table 101. Neuwave Medical Business Overview Table 102. Neuwave Medical Radioactive Iodine Ablation Therapy Sales (units), Value (US$ Million), Price (M USD$/units) and Gross Margin (2021-2026) Table 103. Neuwave Medical Radioactive Iodine Ablation Therapy Product Portfolio Table 104. Neuwave Medical Recent Development Table 105. Key Raw Materials Table 106. Raw Materials Key Suppliers Table 107. Radioactive Iodine Ablation Therapy Distributors List Table 108. Radioactive Iodine Ablation Therapy Customers List Table 109. Research Programs/Design for This Report Table 110. Authors List of This Report Table 111. Secondary Sources Table 112. Primary Sources List of Figures Figure 1. Radioactive Iodine Ablation Therapy Product Image Figure 2. Global Radioactive Iodine Ablation Therapy Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Radioactive Iodine Ablation Therapy Sales Value (2021-2032) & (US$ Million) Figure 4. Global Radioactive Iodine Ablation Therapy Sales (2021-2032) & (units) Figure 5. Global Radioactive Iodine Ablation Therapy Sales Average Price (M USD$/units) & (2021-2032) Figure 6. Global Radioactive Iodine Ablation Therapy Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Gamma Radiation Image Figure 10. Beta Radiation Image Figure 11. Global Radioactive Iodine Ablation Therapy Sales Volume by Type (2021 VS 2025 VS 2032) & (units) Figure 12. Global Radioactive Iodine Ablation Therapy Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Radioactive Iodine Ablation Therapy Sales Volume Share by Type (2021-2032) Figure 14. Global Radioactive Iodine Ablation Therapy Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Radioactive Iodine Ablation Therapy Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Radioactive Iodine Ablation Therapy Sales Value Share by Type (2021-2032) Figure 17. Papillary Thyroid Cancer Image Figure 18. Follicular Thyroid Cancer Image Figure 19. Hurthle Cell Carcinoma Image Figure 20. Other Image Figure 21. Global Radioactive Iodine Ablation Therapy Sales Volume by Application (2021 VS 2025 VS 2032) & (units) Figure 22. Global Radioactive Iodine Ablation Therapy Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Radioactive Iodine Ablation Therapy Sales Volume Share by Application (2021-2032) Figure 24. Global Radioactive Iodine Ablation Therapy Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Radioactive Iodine Ablation Therapy Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Radioactive Iodine Ablation Therapy Sales Value Share by Application (2021-2032) Figure 27. Global Radioactive Iodine Ablation Therapy Sales by Region: 2021 VS 2025 VS 2032 (units) Figure 28. Global Radioactive Iodine Ablation Therapy Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Radioactive Iodine Ablation Therapy Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Radioactive Iodine Ablation Therapy Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Radioactive Iodine Ablation Therapy Sales Value (2021-2032) & (US$ Million) Figure 32. North America Radioactive Iodine Ablation Therapy Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Radioactive Iodine Ablation Therapy Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Radioactive Iodine Ablation Therapy Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Radioactive Iodine Ablation Therapy Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Radioactive Iodine Ablation Therapy Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Radioactive Iodine Ablation Therapy Sales Value (2021-2032) & (US$ Million) Figure 38. South America Radioactive Iodine Ablation Therapy Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Radioactive Iodine Ablation Therapy Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Radioactive Iodine Ablation Therapy Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Radioactive Iodine Ablation Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Radioactive Iodine Ablation Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Radioactive Iodine Ablation Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Radioactive Iodine Ablation Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Radioactive Iodine Ablation Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Radioactive Iodine Ablation Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Radioactive Iodine Ablation Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Radioactive Iodine Ablation Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Radioactive Iodine Ablation Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Radioactive Iodine Ablation Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Radioactive Iodine Ablation Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Radioactive Iodine Ablation Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Radioactive Iodine Ablation Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Radioactive Iodine Ablation Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Radioactive Iodine Ablation Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Radioactive Iodine Ablation Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Radioactive Iodine Ablation Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Radioactive Iodine Ablation Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Radioactive Iodine Ablation Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Radioactive Iodine Ablation Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Radioactive Iodine Ablation Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Radioactive Iodine Ablation Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Radioactive Iodine Ablation Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Radioactive Iodine Ablation Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Radioactive Iodine Ablation Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Radioactive Iodine Ablation Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Radioactive Iodine Ablation Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Radioactive Iodine Ablation Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Radioactive Iodine Ablation Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Radioactive Iodine Ablation Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Radioactive Iodine Ablation Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Radioactive Iodine Ablation Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Radioactive Iodine Ablation Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Radioactive Iodine Ablation Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Radioactive Iodine Ablation Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Radioactive Iodine Ablation Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Radioactive Iodine Ablation Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Radioactive Iodine Ablation Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Radioactive Iodine Ablation Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Radioactive Iodine Ablation Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Radioactive Iodine Ablation Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Radioactive Iodine Ablation Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Radioactive Iodine Ablation Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Radioactive Iodine Ablation Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Radioactive Iodine Ablation Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Radioactive Iodine Ablation Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Radioactive Iodine Ablation Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Radioactive Iodine Ablation Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Radioactive Iodine Ablation Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Radioactive Iodine Ablation Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Radioactive Iodine Ablation Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Radioactive Iodine Ablation Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Radioactive Iodine Ablation Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Radioactive Iodine Ablation Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Radioactive Iodine Ablation Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Radioactive Iodine Ablation Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Radioactive Iodine Ablation Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Radioactive Iodine Ablation Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Radioactive Iodine Ablation Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Radioactive Iodine Ablation Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Radioactive Iodine Ablation Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Radioactive Iodine Ablation Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Radioactive Iodine Ablation Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Radioactive Iodine Ablation Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Radioactive Iodine Ablation Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Radioactive Iodine Ablation Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Radioactive Iodine Ablation Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Radioactive Iodine Ablation Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Radioactive Iodine Ablation Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Radioactive Iodine Ablation Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Radioactive Iodine Ablation Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Radioactive Iodine Ablation Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Radioactive Iodine Ablation Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Radioactive Iodine Ablation Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Radioactive Iodine Ablation Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Radioactive Iodine Ablation Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Radioactive Iodine Ablation Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Radioactive Iodine Ablation Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Radioactive Iodine Ablation Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Radioactive Iodine Ablation Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Radioactive Iodine Ablation Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Radioactive Iodine Ablation Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Radioactive Iodine Ablation Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Radioactive Iodine Ablation Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Radioactive Iodine Ablation Therapy Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Radioactive Iodine Ablation Therapy Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Gamma Radiation
  • Beta Radiation
Applications
  • Papillary Thyroid Cancer
  • Follicular Thyroid Cancer
  • Hurthle Cell Carcinoma
  • Other
Companies covered
  • Medtronic
  • HealthTronics
  • Galil Medical
  • AngioDynamics
  • Misonix
  • SonaCare Medical
  • Boston Scientific Corporation
  • Neuwave Medical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Radioactive Iodine Ablation Therapy Sales Value (2021-2032)
  4. 1.2.2 Global Radioactive Iodine Ablation Therapy Sales Volume (2021-2032)
  5. 1.2.3 Global Radioactive Iodine Ablation Therapy Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Radioactive Iodine Ablation Therapy Market Dynamics
  1. 2.1 Radioactive Iodine Ablation Therapy Industry Trends
  2. 2.2 Radioactive Iodine Ablation Therapy Industry Drivers
  3. 2.3 Radioactive Iodine Ablation Therapy Industry Opportunities and Challenges
  4. 2.4 Radioactive Iodine Ablation Therapy Industry Restraints
3 Radioactive Iodine Ablation Therapy Market by Company
  1. 3.1 Global Radioactive Iodine Ablation Therapy Company Revenue Ranking in 2025
  2. 3.2 Global Radioactive Iodine Ablation Therapy Revenue by Company (2021-2026)
  3. 3.3 Global Radioactive Iodine Ablation Therapy Sales Volume by Company (2021-2026)
  4. 3.4 Global Radioactive Iodine Ablation Therapy Average Price by Company (2021-2026)
  5. 3.5 Global Radioactive Iodine Ablation Therapy Company Ranking (2024-2026)
  6. 3.6 Global Radioactive Iodine Ablation Therapy Company Manufacturing Base and Headquarters
  7. 3.7 Global Radioactive Iodine Ablation Therapy Company Product Type and Application
  8. 3.8 Global Radioactive Iodine Ablation Therapy Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Radioactive Iodine Ablation Therapy Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Radioactive Iodine Ablation Therapy Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Radioactive Iodine Ablation Therapy Market by Type
  1. 4.1 Radioactive Iodine Ablation Therapy Type Introduction
  2. 4.1.1 Gamma Radiation
  3. 4.1.2 Beta Radiation
  4. 4.2 Global Radioactive Iodine Ablation Therapy Sales Volume by Type
  5. 4.2.1 Global Radioactive Iodine Ablation Therapy Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Radioactive Iodine Ablation Therapy Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Radioactive Iodine Ablation Therapy Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Radioactive Iodine Ablation Therapy Sales Value by Type
  9. 4.3.1 Global Radioactive Iodine Ablation Therapy Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Radioactive Iodine Ablation Therapy Sales Value by Type (2021-2032)
  11. 4.3.3 Global Radioactive Iodine Ablation Therapy Sales Value Share by Type (2021-2032)
5 Radioactive Iodine Ablation Therapy Market by Application
  1. 5.1 Radioactive Iodine Ablation Therapy Application Introduction
  2. 5.1.1 Papillary Thyroid Cancer
  3. 5.1.2 Follicular Thyroid Cancer
  4. 5.1.3 Hurthle Cell Carcinoma
  5. 5.1.4 Other
  6. 5.2 Global Radioactive Iodine Ablation Therapy Sales Volume by Application
  7. 5.2.1 Global Radioactive Iodine Ablation Therapy Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Radioactive Iodine Ablation Therapy Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Radioactive Iodine Ablation Therapy Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Radioactive Iodine Ablation Therapy Sales Value by Application
  11. 5.3.1 Global Radioactive Iodine Ablation Therapy Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Radioactive Iodine Ablation Therapy Sales Value by Application (2021-2032)
  13. 5.3.3 Global Radioactive Iodine Ablation Therapy Sales Value Share by Application (2021-2032)
6 Radioactive Iodine Ablation Therapy Regional Sales and Value Analysis
  1. 6.1 Global Radioactive Iodine Ablation Therapy Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Radioactive Iodine Ablation Therapy Sales by Region (2021-2032)
  3. 6.2.1 Global Radioactive Iodine Ablation Therapy Sales by Region: 2021-2026
  4. 6.2.2 Global Radioactive Iodine Ablation Therapy Sales by Region (2027-2032)
  5. 6.3 Global Radioactive Iodine Ablation Therapy Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Radioactive Iodine Ablation Therapy Sales Value by Region (2021-2032)
  7. 6.4.1 Global Radioactive Iodine Ablation Therapy Sales Value by Region: 2021-2026
  8. 6.4.2 Global Radioactive Iodine Ablation Therapy Sales Value by Region (2027-2032)
  9. 6.5 Global Radioactive Iodine Ablation Therapy Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Radioactive Iodine Ablation Therapy Sales Value (2021-2032)
  12. 6.6.2 North America Radioactive Iodine Ablation Therapy Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Radioactive Iodine Ablation Therapy Sales Value (2021-2032)
  15. 6.7.2 Europe Radioactive Iodine Ablation Therapy Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Radioactive Iodine Ablation Therapy Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Radioactive Iodine Ablation Therapy Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Radioactive Iodine Ablation Therapy Sales Value (2021-2032)
  21. 6.9.2 South America Radioactive Iodine Ablation Therapy Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Radioactive Iodine Ablation Therapy Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Radioactive Iodine Ablation Therapy Sales Value Share by Country, 2025 VS 2032
7 Radioactive Iodine Ablation Therapy Country-level Sales and Value Analysis
  1. 7.1 Global Radioactive Iodine Ablation Therapy Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Radioactive Iodine Ablation Therapy Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Radioactive Iodine Ablation Therapy Sales by Country (2021-2032)
  4. 7.3.1 Global Radioactive Iodine Ablation Therapy Sales by Country (2021-2026)
  5. 7.3.2 Global Radioactive Iodine Ablation Therapy Sales by Country (2027-2032)
  6. 7.4 Global Radioactive Iodine Ablation Therapy Sales Value by Country (2021-2032)
  7. 7.4.1 Global Radioactive Iodine Ablation Therapy Sales Value by Country (2021-2026)
  8. 7.4.2 Global Radioactive Iodine Ablation Therapy Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Radioactive Iodine Ablation Therapy Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Radioactive Iodine Ablation Therapy Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Radioactive Iodine Ablation Therapy Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Radioactive Iodine Ablation Therapy Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Radioactive Iodine Ablation Therapy Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Radioactive Iodine Ablation Therapy Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Radioactive Iodine Ablation Therapy Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Radioactive Iodine Ablation Therapy Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Radioactive Iodine Ablation Therapy Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Radioactive Iodine Ablation Therapy Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Radioactive Iodine Ablation Therapy Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Radioactive Iodine Ablation Therapy Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Radioactive Iodine Ablation Therapy Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Radioactive Iodine Ablation Therapy Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Radioactive Iodine Ablation Therapy Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Radioactive Iodine Ablation Therapy Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Radioactive Iodine Ablation Therapy Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Radioactive Iodine Ablation Therapy Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Radioactive Iodine Ablation Therapy Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Radioactive Iodine Ablation Therapy Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Radioactive Iodine Ablation Therapy Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Radioactive Iodine Ablation Therapy Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Radioactive Iodine Ablation Therapy Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Radioactive Iodine Ablation Therapy Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Radioactive Iodine Ablation Therapy Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Radioactive Iodine Ablation Therapy Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Radioactive Iodine Ablation Therapy Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Radioactive Iodine Ablation Therapy Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Radioactive Iodine Ablation Therapy Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Radioactive Iodine Ablation Therapy Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Radioactive Iodine Ablation Therapy Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Radioactive Iodine Ablation Therapy Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Radioactive Iodine Ablation Therapy Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Radioactive Iodine Ablation Therapy Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Radioactive Iodine Ablation Therapy Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Radioactive Iodine Ablation Therapy Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Radioactive Iodine Ablation Therapy Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Radioactive Iodine Ablation Therapy Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Radioactive Iodine Ablation Therapy Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Radioactive Iodine Ablation Therapy Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Radioactive Iodine Ablation Therapy Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Radioactive Iodine Ablation Therapy Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Radioactive Iodine Ablation Therapy Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Radioactive Iodine Ablation Therapy Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Radioactive Iodine Ablation Therapy Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Radioactive Iodine Ablation Therapy Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Radioactive Iodine Ablation Therapy Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Radioactive Iodine Ablation Therapy Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Radioactive Iodine Ablation Therapy Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Radioactive Iodine Ablation Therapy Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Radioactive Iodine Ablation Therapy Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Radioactive Iodine Ablation Therapy Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Radioactive Iodine Ablation Therapy Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Radioactive Iodine Ablation Therapy Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Radioactive Iodine Ablation Therapy Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Radioactive Iodine Ablation Therapy Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Radioactive Iodine Ablation Therapy Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Radioactive Iodine Ablation Therapy Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Radioactive Iodine Ablation Therapy Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Radioactive Iodine Ablation Therapy Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Radioactive Iodine Ablation Therapy Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Radioactive Iodine Ablation Therapy Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Radioactive Iodine Ablation Therapy Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Radioactive Iodine Ablation Therapy Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Radioactive Iodine Ablation Therapy Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Radioactive Iodine Ablation Therapy Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Radioactive Iodine Ablation Therapy Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Radioactive Iodine Ablation Therapy Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Radioactive Iodine Ablation Therapy Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Radioactive Iodine Ablation Therapy Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Radioactive Iodine Ablation Therapy Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Radioactive Iodine Ablation Therapy Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Radioactive Iodine Ablation Therapy Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Radioactive Iodine Ablation Therapy Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Radioactive Iodine Ablation Therapy Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Radioactive Iodine Ablation Therapy Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Radioactive Iodine Ablation Therapy Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Radioactive Iodine Ablation Therapy Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Radioactive Iodine Ablation Therapy Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Radioactive Iodine Ablation Therapy Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Radioactive Iodine Ablation Therapy Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Radioactive Iodine Ablation Therapy Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Radioactive Iodine Ablation Therapy Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Radioactive Iodine Ablation Therapy Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Medtronic
  2. 8.1.1 Medtronic Company Information
  3. 8.1.2 Medtronic Business Overview
  4. 8.1.3 Medtronic Radioactive Iodine Ablation Therapy Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Medtronic Radioactive Iodine Ablation Therapy Product Portfolio
  6. 8.1.5 Medtronic Recent Developments
  7. 8.2 HealthTronics
  8. 8.2.1 HealthTronics Company Information
  9. 8.2.2 HealthTronics Business Overview
  10. 8.2.3 HealthTronics Radioactive Iodine Ablation Therapy Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 HealthTronics Radioactive Iodine Ablation Therapy Product Portfolio
  12. 8.2.5 HealthTronics Recent Developments
  13. 8.3 Galil Medical
  14. 8.3.1 Galil Medical Company Information
  15. 8.3.2 Galil Medical Business Overview
  16. 8.3.3 Galil Medical Radioactive Iodine Ablation Therapy Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Galil Medical Radioactive Iodine Ablation Therapy Product Portfolio
  18. 8.3.5 Galil Medical Recent Developments
  19. 8.4 AngioDynamics
  20. 8.4.1 AngioDynamics Company Information
  21. 8.4.2 AngioDynamics Business Overview
  22. 8.4.3 AngioDynamics Radioactive Iodine Ablation Therapy Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 AngioDynamics Radioactive Iodine Ablation Therapy Product Portfolio
  24. 8.4.5 AngioDynamics Recent Developments
  25. 8.5 Misonix
  26. 8.5.1 Misonix Company Information
  27. 8.5.2 Misonix Business Overview
  28. 8.5.3 Misonix Radioactive Iodine Ablation Therapy Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Misonix Radioactive Iodine Ablation Therapy Product Portfolio
  30. 8.5.5 Misonix Recent Developments
  31. 8.6 SonaCare Medical
  32. 8.6.1 SonaCare Medical Company Information
  33. 8.6.2 SonaCare Medical Business Overview
  34. 8.6.3 SonaCare Medical Radioactive Iodine Ablation Therapy Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 SonaCare Medical Radioactive Iodine Ablation Therapy Product Portfolio
  36. 8.6.5 SonaCare Medical Recent Developments
  37. 8.7 Boston Scientific Corporation
  38. 8.7.1 Boston Scientific Corporation Company Information
  39. 8.7.2 Boston Scientific Corporation Business Overview
  40. 8.7.3 Boston Scientific Corporation Radioactive Iodine Ablation Therapy Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Boston Scientific Corporation Radioactive Iodine Ablation Therapy Product Portfolio
  42. 8.7.5 Boston Scientific Corporation Recent Developments
  43. 8.8 Neuwave Medical
  44. 8.8.1 Neuwave Medical Company Information
  45. 8.8.2 Neuwave Medical Business Overview
  46. 8.8.3 Neuwave Medical Radioactive Iodine Ablation Therapy Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Neuwave Medical Radioactive Iodine Ablation Therapy Product Portfolio
  48. 8.8.5 Neuwave Medical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Radioactive Iodine Ablation Therapy Value Chain Analysis
  2. 9.1.1 Radioactive Iodine Ablation Therapy Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Radioactive Iodine Ablation Therapy Sales Mode & Process
  6. 9.2 Radioactive Iodine Ablation Therapy Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Radioactive Iodine Ablation Therapy Distributors
  9. 9.2.3 Radioactive Iodine Ablation Therapy Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst